-
Article
Open AccessPredictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial
Identifying patients with metastatic colorectal cancer who will have an early disease progression during induction chemotherapy (IC) and identifying patients who may have a chemotherapy-free interval (CFI) aft...
-
Article
Open AccessDistinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Recent studies have offered ample insight into genome-wide expression patterns to define pancreatic ductal adenocarcinoma (PDAC) subtypes, although there remains a lack of knowledge regarding the underlying ep...
-
Article
Open AccessGravity Data from the Teboursouk Area (“Diapirs Zone”, Northern Tunisia): Characterization of Deep Structures and Updated Tectonic Pattern
Located between eastern segments of the Atlas and Tell-Rif oro-genic belts, the “Dome zone” of northern Tunisia is characterized by the juxtaposition of various structures that mainly controlled the long geody...
-
Article
Open AccessPharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer
We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorect...